LACTOLOGY FOUNDATION

This subgroup includes rectal preparations used as enemas for short‑term relief of constipation and bowel cleansing; available safety data indicate that most A06AG medicines are compatible with breastfeeding when used appropriately and without exceeding recommended doses.medpedia.framar+3

ATC subgroup overview

ATC code A06AG comprises enemas, regardless of their pharmacological mechanism of action, within the broader “drugs for constipation” group (A06).atcddd.fhi+3
The subgroup includes sodium phosphate, bisacodyl, dantron (including combinations), glycerol, mineral oil preparations, sorbitol, docusate sodium (including combinations), laurilsulfate (including combinations), and other combinations.naver+2

General pharmacology of enemas

Enemas deliver a liquid or semi‑solid preparation into the rectum, where it acts locally to stimulate defecation or soften stool, and are used for bowel cleansing before diagnostic or surgical procedures and for short‑term treatment of constipation.medlineplus+2
They may exert osmotic effects (drawing water into the intestinal lumen), stimulant effects on colonic motility, or stool‑softening/surfactant effects, depending on the active substance.medlineplus+3

Sodium phosphate enemas (A06AG01)

Rectal sodium phosphate is a saline laxative that works osmotically by drawing water into the large intestine, producing a soft bowel movement and rapid evacuation.atcddd.fhi+1
Systemic absorption can cause electrolyte disturbances, particularly hyperphosphatemia and hypocalcemia, mainly in susceptible adults (elderly, renal impairment, heart failure) or with repeated/high‑volume use.medlineplus

Toxicological considerations

Serious toxicity is chiefly related to acute phosphate and fluid load: cases of acute kidney injury, arrhythmias, and metabolic disturbances have been described after misuse or overdose, especially in patients with pre‑existing renal or cardiovascular disease.journals.sagepub+2
Use is contraindicated or requires particular caution in patients with renal insufficiency, congestive heart failure, electrolyte imbalance, bowel obstruction, or in very young children, and should not exceed recommended doses or frequency.medlineplus

Lactation safety

Available data and expert sources indicate that use of sodium phosphate for bowel evacuation, including rectal enemas, does not require interruption of breastfeeding, because systemic exposure in the mother is short and transfer into milk is minimal.breastfeeding-and-medication+2
No adverse effects have been reported in breastfed infants after maternal use of phosphate enemas at therapeutic doses; routine timing adjustments or discarding of milk are not considered necessary.ncbi.nlm.nih+2

Bisacodyl enemas (A06AG02)

Bisacodyl is a stimulant laxative that increases intestinal motility, promoting bowel movements; rectal formulations produce rapid effect and are used short term for constipation or bowel preparation.webmd+2
Systemic absorption after rectal administration is limited, and most of the effect is local in the distal colon.medlineplus+1

Toxicological considerations

Adverse effects include abdominal cramping, diarrhea, rectal irritation, and, rarely, electrolyte disturbances with excessive use or in vulnerable patients.webmd+1
Long‑term or abusive use of stimulant laxatives can theoretically contribute to colon dysfunction, so bisacodyl enemas should be reserved for occasional, short‑term indications.medlineplus+1

Lactation safety

Because systemic exposure of the mother is low and bisacodyl’s local action predominates, clinically significant passage into breast milk is unlikely, and use of rectal bisacodyl at usual doses is generally considered compatible with breastfeeding.journals.sagepub+1
No specific reports of toxicity in breastfed infants have been identified, but, as with other stimulant laxatives, unnecessary prolonged use in the mother should be avoided.journals.sagepub+1

Dantron enemas (A06AG03)

Dantron (also known as dantrolene‑type anthracene derivative in older classifications) is a stimulant laxative that acts on the colon to increase peristalsis; it may be formulated alone or in combinations.atcddd.fhi+2
Its use has declined in many markets because of concerns about carcinogenic potential observed in animal studies, and in some countries dantron‑containing products are restricted or unavailable.atcddd.fhi+1

Toxicological considerations

Toxicology concerns are mainly long‑term carcinogenic risk based on preclinical data, rather than acute systemic toxicity; hepatotoxicity has also been discussed in relation to prolonged use.naver+1
Because of these issues, dantron is generally not recommended for chronic constipation management and should be avoided in vulnerable populations, including pregnant and lactating women, when safer alternatives exist.atcddd.fhi+1

Lactation safety

Human data on dantron during breastfeeding are extremely limited, and, given the theoretical carcinogenic risk, most expert sources recommend preferring other laxatives with established safety profiles in lactating women.atcddd.fhi+1
If a dantron enema is used once for urgent bowel evacuation, clinically relevant exposure to the infant is probably low, but repeated use during breastfeeding is not advisable.journals.sagepub+1

Glycerol enemas (A06AG04)

Rectal glycerol (glycerin) acts as a hyperosmotic agent and mild irritant, drawing water into the rectum and stimulating peristalsis to relieve occasional constipation.clevelandclinic+1
Its systemic absorption from the rectal route is minimal and it is considered a gentle, local treatment option, including in pediatric practice.clevelandclinic

Toxicological considerations

Adverse effects are usually limited to local discomfort, rectal irritation, or transient cramping; clinically significant systemic toxicity is rare at recommended doses.clevelandclinic
Overuse can lead to dependence on rectal stimulation in susceptible individuals, so it should be used for short periods only.clevelandclinic

Lactation safety

Because glycerol is an endogenous substance and exposure from rectal use is small, passage into milk is not expected to pose any risk; professional guidance lists glycerol rectal preparations as compatible with breastfeeding.journals.sagepub+1
No adverse effects in breastfed infants have been reported in association with maternal use of glycerin suppositories or enemas.clevelandclinic+1

Mineral oil and sorbitol enemas (A06AG06, A06AG07)

Mineral oil (liquid paraffin) enemas act primarily as stool lubricants and softeners, facilitating evacuation without significant systemic absorption.atcddd.fhi+1
Sorbitol enemas exert an osmotic effect, drawing water into the bowel lumen and triggering defecation, with limited systemic exposure from rectal use.naver+1

Toxicological considerations

Mineral oil given orally can, in rare cases, be aspirated, but this risk is much lower with rectal administration; occasional rectal use at therapeutic doses is generally safe in adults.naver
Sorbitol enemas may cause diarrhea, cramping, and fluid/electrolyte shifts if overused or in high volumes, especially in patients with cardiac or renal disease.naver

Lactation safety

With rectal mineral oil, clinically significant maternal systemic absorption is low and transfer into breast milk is negligible, so occasional use is considered compatible with breastfeeding.naver+1
Sorbitol enemas, used within recommended limits, are likewise regarded as low‑risk for the breastfed infant, and routine breastfeeding interruption is not indicated.journals.sagepub+1

Docusate sodium and laurilsulfate enemas (A06AG10, A06AG11)

Docusate sodium is a surfactant stool softener that decreases stool surface tension, allowing water and lipids to penetrate; rectal formulations are used when oral administration is not feasible or rapid local action is desired.atcddd.fhi+1
Laurilsulfate preparations act as wetting agents and mild irritants to promote colonic emptying, sometimes in combination with other laxatives in enema form.atcddd.fhi+1

Toxicological considerations

Docusate is generally well tolerated, though very prolonged or high‑dose use has been associated with rare electrolyte disturbances; rectal use can cause local irritation or cramping.naver
Laurilsulfate enemas may provoke rectal irritation or diarrhea if misused; systemic toxicity at usual doses is uncommon.naver

Lactation safety

Docusate has long experience in breastfeeding women, and both oral and rectal forms are widely considered compatible with lactation, with negligible concentrations found in breast milk.journals.sagepub+1
Laurilsulfate‑containing enemas used at therapeutic doses are not expected to result in clinically relevant infant exposure, and standard references classify stool softeners and related agents among the preferred options when breastfeeding mothers need laxatives.journals.sagepub+1

Combination enemas (A06AG20)

Some A06AG products combine osmotic, stimulant, and surfactant agents in a single enema to achieve rapid and complete bowel evacuation, especially prior to endoscopy or surgery.medpedia.framar+2
Toxicological and lactation considerations for these preparations are determined by the individual components, with particular attention to phosphate load and stimulant content in high‑volume or repeated regimens.medpedia.framar+3

Overall lactation‑toxicology assessment

Across the A06AG subgroup, rectal administration produces mainly local effects in the distal colon, and systemic exposure of the mother is generally lower than with oral formulations, reducing the potential for transfer into breast milk.medpedia.framar+3
Available evidence and expert guidance indicate that single‑dose or short‑course use of sodium phosphate, bisacodyl, glycerol, mineral oil, sorbitol, docusate sodium, and related enemas does not require interruption of breastfeeding, provided maternal contraindications are respected and dosing remains within recommended limits.breastfeeding-and-medication+3

Clinicians should exercise caution with products containing dantron or high phosphate content in mothers with renal or cardiovascular disease, and in all cases should monitor for maternal adverse effects such as electrolyte imbalance, dehydration, or severe diarrhea that could indirectly impact lactation.ncbi.nlm.nih+3
When choosing an enema for a breastfeeding woman, preference should be given to agents with favorable lactation safety profiles and long clinical experience (e.g., glycerol or docusate), while avoiding unnecessary repeated use of stimulant or high‑phosphate preparations.ncbi.nlm.nih+2